These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35299705)

  • 21. Coexistence of amyloidosis and light chain deposition disease in the heart.
    Sobue Y; Takemura G; Kawamura S; Yano T; Kanamori H; Morimoto SI; Matsuo H
    Cardiovasc Pathol; 2021; 51():107315. PubMed ID: 33264681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac amyloidosis: a practical approach to diagnosis and management.
    Kapoor P; Thenappan T; Singh E; Kumar S; Greipp PR
    Am J Med; 2011 Nov; 124(11):1006-15. PubMed ID: 22017778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients.
    Comenzo RL; Vosburgh E; Falk RH; Sanchorawala V; Reisinger J; Dubrey S; Dember LM; Berk JL; Akpek G; LaValley M; O'hara C; Arkin CF; Wright DG; Skinner M
    Blood; 1998 May; 91(10):3662-70. PubMed ID: 9573002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sudden death in lambda light chain AL cardiac amyloidosis: a review of literature and update for clinicians and pathologists.
    D'Errico S; Mazzanti A; Baldari B; Maiese A; Frati P; Fineschi V
    Int J Clin Exp Pathol; 2020; 13(7):1474-1482. PubMed ID: 32782665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis: Redefining Early Disease?
    Cuddy SAM; Bravo PE; Falk RH; El-Sady S; Kijewski MF; Park MA; Ruberg FL; Sanchorawala V; Landau H; Yee AJ; Bianchi G; Di Carli MF; Cheng SC; Jerosch-Herold M; Kwong RY; Liao R; Dorbala S
    JACC Cardiovasc Imaging; 2020 Jun; 13(6):1325-1336. PubMed ID: 32417333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myocardial infarction with "clean coronaries" caused by amyloid light-chain AL amyloidosis: a case report and literature review.
    Tsai SB; Seldin DC; Wu H; O'Hara C; Ruberg FL; Sanchorawala V
    Amyloid; 2011 Sep; 18(3):160-4. PubMed ID: 21504342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ten-year follow-up after autologous stem cell transplantation of a patient with immunoglobulin light-chain (AL) amyloidosis with deposits in the heart, liver and gastrointestinal tract.
    Mejhert M; Hast R; Sandstedt B; Janczewska I
    BMJ Case Rep; 2011 Aug; 2011():. PubMed ID: 22688930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infusion of light chains from patients with cardiac amyloidosis causes diastolic dysfunction in isolated mouse hearts.
    Liao R; Jain M; Teller P; Connors LH; Ngoy S; Skinner M; Falk RH; Apstein CS
    Circulation; 2001 Oct; 104(14):1594-7. PubMed ID: 11581134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis.
    Sanchorawala V; Wright DG; Seldin DC; Dember LM; Finn K; Falk RH; Berk J; Quillen K; Skinner M
    Bone Marrow Transplant; 2001 Oct; 28(7):637-42. PubMed ID: 11704785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac amyloidosis: updates in diagnosis and management.
    Mohty D; Damy T; Cosnay P; Echahidi N; Casset-Senon D; Virot P; Jaccard A
    Arch Cardiovasc Dis; 2013 Oct; 106(10):528-40. PubMed ID: 24070600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myocardial Amyloidosis: The Exemplar Interstitial Disease.
    Fontana M; Ćorović A; Scully P; Moon JC
    JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2345-2356. PubMed ID: 31422120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Congo red-positive cardiac kappa-AL amyloidosis in plasmacytoma -- case report and review of the literature.
    Tzankov A; Pölzl G; Mairinger T
    Acta Med Austriaca; 2003; 30(1):29-32. PubMed ID: 12558564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac amyloidosis presenting as pulmonary arterial hypertension: A case report.
    Gao M; Zhang WH; Zhang ZG; Yang N; Tong Q; Chen LP
    World J Clin Cases; 2023 Apr; 11(12):2780-2787. PubMed ID: 37214585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current treatment in cardiac amyloidosis.
    Kholová I; Kautzner J
    Curr Treat Options Cardiovasc Med; 2006 Dec; 8(6):468-73. PubMed ID: 17078911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Marked recovery of cardiac function by chemotherapy and autologous stem cell transplantation of a patient with heart failure with preserved ejection fraction due to primary amyloid light-chain amyloidosis: a case report.
    Tanaka H; Kitao A; Minami H; Hirata KI
    Eur Heart J Case Rep; 2022 Mar; 6(3):ytac016. PubMed ID: 35291337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pittsburgh B Compound Positron Emission Tomography in Patients With AL Cardiac Amyloidosis.
    Lee SP; Suh HY; Park S; Oh S; Kwak SG; Kim HM; Koh Y; Park JB; Kim HK; Cho HJ; Kim YJ; Kim I; Yoon SS; Seo JW; Paeng JC; Sohn DW
    J Am Coll Cardiol; 2020 Feb; 75(4):380-390. PubMed ID: 32000949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Need for Early Recognition of Amyloidosis in Cases of Unexplained Heart Failure: A Case Report.
    Kalluri S; Abbasi J
    Cureus; 2023 Jun; 15(6):e40658. PubMed ID: 37342296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel variant of transthyretin, 59Thr-->Lys, associated with autosomal dominant cardiac amyloidosis in an Italian family.
    Booth DR; Tan SY; Hawkins PN; Pepys MB; Frustaci A
    Circulation; 1995 Feb; 91(4):962-7. PubMed ID: 7850982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fatal cardiac arrhythmia after infusion of dimethyl sulfoxide-cryopreserved hematopoietic stem cells in a patient with severe primary cardiac amyloidosis and end-stage renal failure.
    Zenhäusern R; Tobler A; Leoncini L; Hess OM; Ferrari P
    Ann Hematol; 2000 Sep; 79(9):523-6. PubMed ID: 11043425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autologous stem-cell transplantation in progressing amyloidosis is associated with severe transplant-related toxicity.
    Worel N; Schulenburg A; Mitterbauer M; Keil F; Rabitsch W; Kalhs P; Gisslinger H; Raderer M; Geissler K; Höcker P; Zielinski CC; Oberbauer R; Greinix HT
    Wien Klin Wochenschr; 2006 Feb; 118(1-2):49-53. PubMed ID: 16489526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.